Shares of Adeia Corp. cratered more than 20% to $16.41 after the patent-licensing company posted third-quarter results that missed Wall Street targets by a wide margin and slashed its full-year outlook — a brutal first earnings report for new chief executive Dipti Vachani, who took the helm just three weeks earlier.
• Revenue Fell 19% Below Estimates, Exposing Licensing's Timing Problem
Revenue was $80.2 million, down from $96.1 million in the second quarter of 2026 , and far short of the $98.88 million analysts had expected . Non-GAAP diluted EPS came in at $0.21 , missing the $0.30 consensus. Adeia's business model depends on large, lumpy licensing deals that can swing dramatically quarter to quarter. Management touted eight license agreements signed in the quarter, including renewals with Charter and TCL , but those deals clearly did not translate into booked revenue fast enough to cover the gap.
• A $20 Million Guidance Cut Signals Deals Are Slipping Into 2027
Adeia now expects 2026 revenue of $375–$415 million, down from $395–$435 million previously . The $20 million midpoint reduction tells investors that several contracts management had been counting on for Q4 may not close by year-end. The company said "select deals could execute beyond year-end," a diplomatic way of warning that its back-half-loaded revenue plan has slipped. With nine-month revenue at $281 million , Adeia would need roughly $114 million in Q4 just to hit the new midpoint — a steep sequential climb.
• New CEO Inherits the Pivot Away from Pay-TV
Vachani, who took over October 12 , arrives from Arm, where she developed market-specific IP programs into recurring revenue streams . Her semiconductor pedigree matters: Adeia raised its long-term revenue target to $600 million last quarter, doubling the semiconductor opportunity to $200 million . But today's miss underscores how fragile near-term earnings are while legacy pay-TV revenue fades and newer streams remain deal-dependent.
• The Math Gets Harder for Shareholders At $16.41, Adeia's market capitalization has fallen to roughly $1.8 billion, erasing months of gains. The stock traded above $22 just last week. With $386.5 million in term-loan debt still outstanding and quarterly operating cash flow of just $5.1 million , the balance sheet leaves little margin for further stumbles. Investors are left trusting that delayed deals are merely delayed — not lost — a bet that demands patience the market clearly isn't offering today.